McGuire Institute
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, McGuire Institute sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
McGuire Institute: 7 sponsored US clinical trials, 1 recruiting.
McGuire Institute sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Melanoma In Situ, with 1 trials.
Upper-quartile sponsor footprint
McGuire Institute sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP
NCT06914596
OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier
NCT06447844
Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients
NCT05264545
Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
NCT06919809
Pilot Study for Healing and Safety Outcomes in Gingival Recession
NCT04614350
Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Periodontitis
NCT04169139
An RCT Comparing Xenograft and Allograft for Ridge Preservation
NCT02330523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Where McGuire Institute enrollment is open (later-stage tilt)
1 recruiting of 7 indexed (14% open); 4 completed (57%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Melanoma In Situ (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
McGuire Institute: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
McGuire Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this McGuire Institute page
7 registered trials is a research-attention snapshot, not an endorsement of McGuire Institute or any single study.
- 1 of McGuire Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Melanoma In Situ is the condition McGuire Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Melanoma In Situ trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
McGuire Institute pipeline card: 7 registered trials from official public datasets.Report a data error.